In a filing, Astria Therapeutics Inc revealed its Chief Medical Officer Morabito Christopher unloaded Company’s shares for reported $0.14 million on Apr 01 ’24. In the deal valued at $13.59 per share,10,000 shares were sold. As a result of this transaction, Morabito Christopher now holds 0 shares worth roughly $0.0.
Then, PERCEPTIVE ADVISORS LLC bought 2,481,350 shares, generating $29,999,522 in total proceeds. Upon buying the shares at $12.09, the Director now owns 4,873,721 shares.
Before that, Morabito Christopher sold 9,200 shares. Astria Therapeutics Inc shares valued at $102,552 were divested by the Chief Medical Officer at a price of $11.15 per share. As a result of the transaction, Morabito Christopher now holds 0 shares, worth roughly $0.0.
Evercore ISI initiated its Astria Therapeutics Inc [ATXS] rating to an Outperform in a research note published on March 28, 2023; the price target was $18.
Price Performance Review of ATXS
On Friday, Astria Therapeutics Inc [NASDAQ:ATXS] saw its stock fall -2.34% to $11.27. Over the last five days, the stock has lost -19.93%. Astria Therapeutics Inc shares have risen nearly 46.74% since the year began. Nevertheless, the stocks have fallen -7.40% over the past one year. While a 52-week high of $16.90 was reached on 03/25/24, a 52-week low of $4.26 was recorded on 01/05/24. SMA at 50 days reached $13.95, while 200 days put it at $8.91. A total of 0.89 million shares were traded, compared to the trading of 1.59 million shares in the previous session.
Levels Of Support And Resistance For ATXS Stock
The 24-hour chart illustrates a support level at 11.03, which if violated will result in even more drops to 10.79. On the upside, there is a resistance level at 11.61. A further resistance level may holdings at 11.95. The Relative Strength Index (RSI) on the 14-day chart is 33.04, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.39, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 97.57%. Stochastics %K at 1.68% indicates the stock is a buying.
How much short interest is there in Astria Therapeutics Inc?
A steep rise in short interest was recorded in Astria Therapeutics Inc stocks on Mar 15, 2024, growing by 50000.0 shares to a total of 2.01 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 1.96 million shares. There was a rise of 2.49%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 3.93% of the overall stock float, the days-to-cover ratio (short ratio) rose to 2.09.
